Table 4 Multivariate analysis of risk factors for RMPP development.
Variable | β | SE | Wald | OR (95% CI) | P-value |
---|---|---|---|---|---|
circ_0054633 | 1.838 | 0.425 | 18.656 | 6.28 (2.73–14.47) | < 0.001 |
Fever duration (days) | 0.405 | 0.096 | 17.889 | 1.50 (1.24–1.81) | < 0.001 |
Hypoxemia | 2.364 | 0.691 | 11.713 | 10.64 (2.75–41.20) | 0.001 |
Extrapulmonary complications | 1.081 | 0.470 | 5.296 | 2.95 (1.17–7.40) | 0.021 |
IL-6 (pg/mL) | 0.018 | 0.007 | 6.603 | 1.02 (1.00–1.03) | 0.010 |
Atelectasis | 1.150 | 0.474 | 5.875 | 3.16 (1.25–8.00) | 0.015 |